130 related articles for article (PubMed ID: 3266795)
1. Percutaneous absorption of nicardipine and ketorolac in rhesus monkeys.
Yu D; Sanders LM; Davidson GW; Marvin MJ; Ling T
Pharm Res; 1988 Jul; 5(7):457-62. PubMed ID: 3266795
[TBL] [Abstract][Full Text] [Related]
2. Transdermal delivery of ketorolac tromethamine: permeation enhancement, device design, and pharmacokinetics in healthy humans.
Roy SD; Manoukian E
J Pharm Sci; 1995 Oct; 84(10):1190-6. PubMed ID: 8801333
[TBL] [Abstract][Full Text] [Related]
3. Effect of benzalkonium chloride/EDTA on the ocular bioavailability of ketorolac tromethamine following ocular instillation to normal and de-epithelialized corneas of rabbits.
Madhu C; Rix PJ; Shackleton MJ; Nguyen TG; Tang-Liu DD
J Pharm Sci; 1996 Apr; 85(4):415-8. PubMed ID: 8901080
[TBL] [Abstract][Full Text] [Related]
4. Absorption of transdermally delivered ketorolac acid in humans.
Roy SD; Manoukian E; Combs D
J Pharm Sci; 1995 Jan; 84(1):49-52. PubMed ID: 7714743
[TBL] [Abstract][Full Text] [Related]
5. The excretion of ketorolac tromethamine into breast milk after multiple oral dosing.
Wischnik A; Manth SM; Lloyd J; Bullingham R; Thompson JS
Eur J Clin Pharmacol; 1989; 36(5):521-4. PubMed ID: 2787750
[TBL] [Abstract][Full Text] [Related]
6. Nasal formulations of ketorolac tromethamine: technological evaluation--bioavailability and tolerability in rabbits.
Santus G; Rivolta R; Bottoni G; Testa B; Canali S; Peano S
Farmaco; 1993 Dec; 48(12):1709-23. PubMed ID: 8135994
[TBL] [Abstract][Full Text] [Related]
7. Pharmacokinetics of ketorolac tromethamine in humans after intravenous, intramuscular and oral administration.
Jung D; Mroszczak E; Bynum L
Eur J Clin Pharmacol; 1988; 35(4):423-5. PubMed ID: 3264245
[TBL] [Abstract][Full Text] [Related]
8. Ketorolac tromethamine absorption, distribution, metabolism, excretion, and pharmacokinetics in animals and humans.
Mroszczak EJ; Lee FW; Combs D; Sarnquist FH; Huang BL; Wu AT; Tokes LG; Maddox ML; Cho DK
Drug Metab Dispos; 1987; 15(5):618-26. PubMed ID: 2891477
[TBL] [Abstract][Full Text] [Related]
9. Transdermal delivery of ketorolac tromethamine: effects of vehicles and penetration enhancers.
Cho YA; Gwak HS
Drug Dev Ind Pharm; 2004 Jul; 30(6):557-64. PubMed ID: 15285328
[TBL] [Abstract][Full Text] [Related]
10. In vitro transcorneal permeation of ketorolac tromethamine from buffered and unbuffered aqueous ocular drops.
Malhotra M; Majumdar DK
Indian J Exp Biol; 1997 Sep; 35(9):941-7. PubMed ID: 9475074
[TBL] [Abstract][Full Text] [Related]
11. Ketorolac, an injectable nonnarcotic analgesic.
Litvak KM; McEvoy GK
Clin Pharm; 1990 Dec; 9(12):921-35. PubMed ID: 2292174
[TBL] [Abstract][Full Text] [Related]
12. Clinical pharmacokinetics of ketorolac tromethamine.
Brocks DR; Jamali F
Clin Pharmacokinet; 1992 Dec; 23(6):415-27. PubMed ID: 1458761
[TBL] [Abstract][Full Text] [Related]
13. Pharmacokinetics of ketorolac and p-hydroxyketorolac following oral and intramuscular administration of ketorolac tromethamine.
Jung D; Mroszczak EJ; Wu A; Ling TL; Sevelius H; Bynum L
Pharm Res; 1989 Jan; 6(1):62-5. PubMed ID: 2717521
[TBL] [Abstract][Full Text] [Related]
14. The pharmacokinetics of ketorolac enantiomers following intramuscular administration of the racemate.
Hayball PJ; Wrobel J; Tamblyn JG; Nation RL
Br J Clin Pharmacol; 1994 Jan; 37(1):75-8. PubMed ID: 8148223
[TBL] [Abstract][Full Text] [Related]
15. Ketorolac tromethamine pharmacokinetics and metabolism after intravenous, intramuscular, and oral administration in humans and animals.
Mroszczak EJ; Jung D; Yee J; Bynum L; Sevelius H; Massey I
Pharmacotherapy; 1990; 10(6 ( Pt 2)):33S-39S. PubMed ID: 2082311
[TBL] [Abstract][Full Text] [Related]
16. Ketorolac: an injectable NSAID.
DiPalma JR
Am Fam Physician; 1991 Jan; 43(1):207-10. PubMed ID: 1986489
[TBL] [Abstract][Full Text] [Related]
17. Ketorolac tromethamine.
Med Lett Drugs Ther; 1990 Aug; 32(825):79-81. PubMed ID: 2199809
[No Abstract] [Full Text] [Related]
18. Permeability of ketorolac acid and its ester analogs (prodrug) through human cadaver skin.
Roy SD; Manoukian E
J Pharm Sci; 1994 Nov; 83(11):1548-53. PubMed ID: 7891272
[TBL] [Abstract][Full Text] [Related]
19. Ketorolac. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential.
Buckley MM; Brogden RN
Drugs; 1990 Jan; 39(1):86-109. PubMed ID: 2178916
[TBL] [Abstract][Full Text] [Related]
20. Intraocular penetration of periocular ketorolac and efficacy in experimental uveitis.
Rabiah PK; Fiscella RG; Tessler HH
Invest Ophthalmol Vis Sci; 1996 Mar; 37(4):613-8. PubMed ID: 8595961
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
